−0.0430USD
−16.03 MUSD
148.60 MUSD
313.28 M
About MariMed Inc.
Sector
Industry
CEO
Jon R. Levine
Website
Headquarters
Norwood
Employees (FY)
721
Founded
2011
ISIN
US56782V1070
FIGI
BBG002S0QJN9
MariMed, Inc. engages in direct owning of cannabis licenses and management of seed-to-sale operations. It focuses on the development, operation, management, and optimization of facilities for the cultivation, production, and dispensing of medicinal and recreational cannabis and cannabis-infused products. The company was founded by Robert N. Fireman and Jon Levine on January 25, 2011 and is headquartered in Norwood, MA.
MRMD POTENTIALS...LOOKS GRIMINITIAL THOUGHTS:
The outlined potential H&S is JUST a potential, still needs a lot more confirmation to suggest this entire pattern playing out. However, due to its meteoric rise, and extended 5th wave nature - this correction will likely be much longer and drawn out then ending now.
WE need mor
Double Bottom!12-13-18 and 12-24-18 each formed a low @ 2.35, with increasing RSI on the 24th.
Mr. Trump just signed the hemp bill into law.
This is a buy!
MARIMED - Technical AnalysisDear Traders,
This stock got me exciting 2 days ago, and to see it run as it did is just great. I do think its time for a small retracement but overall feeling is bullish.
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of MRMD is 0.2700 USD — it has decreased by 2.35% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange MariMed Inc. stocks are traded under the ticker MRMD.
MariMed Inc. is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
MRMD stock is 5.94% volatile and has beta coefficient of 1.19. Check out the list of the most volatile stocks — is MariMed Inc. there?
One year price forecast for MariMed Inc. has a max estimate of 0.5000 USD and a min estimate of 0.5000 USD.
MariMed Inc. revenue for the last quarter amounts to 38.80 M USD despite the estimated figure of 39.24 M USD. In the next quarter revenue is expected to reach 39.17 M USD.
Yes, you can track MariMed Inc. financials in yearly and quarterly reports right on TradingView.
MRMD stock has risen by 5.88% compared to the previous week, the month change is a 3.85% rise, over the last year MariMed Inc. has showed a 33.69% decrease.
MRMD net income for the last quarter is −10.17 M USD, while the quarter before that showed −4.26 M USD of net income which accounts for −138.76% change. Track more MariMed Inc. financial stats to get the full picture.
Today MariMed Inc. has the market capitalization of 103.72 M, it has increased by 10.74% over the last week.
No, MRMD doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, MRMD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MariMed Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 20, 2024, the company has 721.00 employees. See our rating of the largest employees — is MariMed Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MariMed Inc. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MariMed Inc. stock shows the sell signal. See more of MariMed Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on MariMed Inc. future price: according to them, MRMD price has a max estimate of 0.50 USD and a min estimate of 0.50 USD. Read a more detailed MariMed Inc. forecast: see what analysts think of MariMed Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MariMed Inc. EBITDA is 23.65 M USD, and current EBITDA margin is 15.92%. See more stats in MariMed Inc. financial statements.